Phase 1 of the PANDA Trial.

The PANDA Trial is a study designed to increase physical activity for people with cardiometabolic diseases aged 45y+ . Phase 1 of the Trial aimed to co-design a nature prescription intervention tailored for communities representative of the Australian public. Phase 1 involved focus group interviews with members of the public and Health or Allied Practitioners. Recruitment and participation in Phase 1 is now closed.  

Phase 2 will involve a Nature Prescription Clinical Trial with members of the public. 

Phase 2 recruitment will be advertised here soon. 

For further information about the study you can contact the study team at panda@unsw.edu.au  or Phone 02 9348 0786 

This study is approved by University of Wollongong HREC (2023/186)